P-366 Phase I study evaluating flavopiridol (HMR1275, FP) in combination with docetaxel (D) in previously treated non-small cell lung cancer (NSCLC) patients (pts.) (HMR1275B/1008)

Lung Cancer ◽  
2003 ◽  
Vol 41 ◽  
pp. S184
Author(s):  
Basil Kasimis ◽  
Caio Rocha-Lima ◽  
Janet Cogswell ◽  
Leslie Rodrigues ◽  
J.J. Mahany ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Previously Treated ◽  
Nsclc Patients

scholarly journals Phase I Study of Amrubicin Hydrochloride and Cisplatin in Patients Previously Treated for Advanced Non-small Cell Lung Cancer

2006 ◽  
Vol 36 (1) ◽  
pp. 12-16 ◽  
Author(s):  
Jiro Ikeda ◽  
Riichiroh Maruyama ◽  
Tatsuro Okamoto ◽  
Fumihiro Shoji ◽  
Hiroshi Wataya ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Previously Treated

scholarly journals A phase I study of foretinib plus erlotinib in patients with previously treated advanced non-small cell lung cancer: Canadian cancer trials group IND.196

Oncotarget ◽  
2017 ◽  
Vol 8 (41) ◽  
pp. 69651-69662 ◽  
Author(s):  
Natasha B. Leighl ◽  
Ming-Sound Tsao ◽  
Geoffrey Liu ◽  
Dongsheng Tu ◽  
Cheryl Ho ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Phase I ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Phase I Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
Previously Treated ◽  
Cancer Trials
Sign in / Sign up

Export Citation Format

Share Document